Abstract
An asymmetric 1,4-addition of arylboronic acids to RCH=CHCO2 Ar
(Ar = Ph or 4-acetylphenyl) was carried out at 50 ˚C
in aqueous acetone in the presence of [Pd(chiraphos)(PhCN)2 ](SbF6 )2 .
The reaction gave optically active β-aryl esters in up to
98% ee. The protocol provided a simple access to an endothelin receptor
antagonist reported by SmithKline Beecham.
Key words
arylboronic acids - palladium catalyst - asymmetric
reaction - conjugate addition - β-arylalkanoate - bioactive compound
References and Notes
<A NAME="RU06208ST-1A">1a </A>
Kurihara K.
Sugishita N.
Oshita K.
Piao D.
Yamamoto Y.
Miyaura N.
J. Organomet.
Chem.
2007,
692:
428
<A NAME="RU06208ST-1B">1b </A>
Hayashi T.
Yamasaki K.
Chem. Rev.
2003,
103:
2829
<A NAME="RU06208ST-1C">1c </A>
Takaya Y.
Ogasawara M.
Hayashi T.
Sakai M.
Miyaura N.
J.
Am. Chem. Soc.
1998,
120:
5579
<A NAME="RU06208ST-2A">2a </A>
He P.
Lu Y.
Dong C.-G.
Hu Q.-S.
Org. Lett.
2007,
9:
343
<A NAME="RU06208ST-2B">2b </A>
Lin S.
Lu X.
Tetrahedron Lett.
2006,
47:
7167
<A NAME="RU06208ST-2C">2c </A>
Denmark SE.
Amishiro N.
J. Org.
Chem.
2003,
68:
6997
<A NAME="RU06208ST-2D">2d </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Angew. Chem.
Int. Ed.
2003,
42:
2768
<A NAME="RU06208ST-2E">2e </A>
Ohe K.
Uemura S.
Bull. Chem. Soc. Jpn.
2003,
76:
1423
<A NAME="RU06208ST-2F">2f </A> For a mechanistic study,
see:
Nishikata T.
Yamamoto Y.
Miyaura N.
Organometallics
2004,
23:
4317
<A NAME="RU06208ST-3A">3a </A>
Zhang T.
Shi M.
Chem.
Eur. J.
2008,
14:
3759
<A NAME="RU06208ST-3B">3b </A>
Song J.
Shen Q.
Xu F.
Lu X.
Org. Lett.
2007,
9:
2947
<A NAME="RU06208ST-3C">3c </A>
Sieber JD.
Liu S.
Morken JP.
J. Am. Chem. Soc.
2007,
129:
2214
<A NAME="RU06208ST-3D">3d </A>
Suzuma Y.
Yamamoto T.
Ohta T.
Ito Y.
Chem. Lett.
2007,
36:
470
<A NAME="RU06208ST-3E">3e </A>
Gini F.
Hessen B.
Minnaard AJ.
Org.
Lett.
2005,
7:
5309
<A NAME="RU06208ST-4A">4a </A>
Yamamoto Y.
Nishikata T.
Miyaura N.
Pure Appl. Chem.
2008,
80:
807
<A NAME="RU06208ST-4B">4b </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Adv.
Synth. Catal.
2007,
349:
1759
<A NAME="RU06208ST-4C">4c </A>
Nishikata T.
Yamamoto Y.
Gridnev ID.
Miyaura N.
Organometallics
2005,
24:
5025
<A NAME="RU06208ST-4D">4d </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Chem.
Lett.
2005,
34:
720
<A NAME="RU06208ST-4E">4e </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Chem. Commun.
2004,
1822
For application of Pd-catalyzed 1,4-addition reaction, see:
<A NAME="RU06208ST-4F">4f </A>
Kobayashi K.
Nishikata T.
Yamamoto Y.
Miyaura N.
Bull. Chem. Soc. Jpn.
2008, in press
<A NAME="RU06208ST-4G">4g </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Tetrahedron
Lett.
2007,
48:
4007
<A NAME="RU06208ST-4H">4h </A>
Nishikata T.
Yamamoto Y.
Miyaura N.
Chem.
Lett.
2007,
36:
1442
<A NAME="RU06208ST-4I">4i </A>
Nishikata T.
Kobayashi Y.
Kobayashi K.
Yamamoto Y.
Miyaura N.
Synlett
2007,
3055
<A NAME="RU06208ST-4J">4j </A>
Itoh T.
Mase T.
Nishikata T.
Iyama T.
Tachikawa H.
Kobayashi Y.
Yamamoto Y.
Miyaura N.
Tetrahedron
2006,
62:
9610
<A NAME="RU06208ST-5A">5a </A>
Du X.
Suguro M.
Hirabayashi K.
Mori A.
Nishikata T.
Hagiwara N.
Kawata K.
Okeda T.
Wang H.-F.
Fugami K.
Kosugi M.
Org.
Lett.
2001,
3:
3313
<A NAME="RU06208ST-5B">5b </A>
Cho CS.
Motofusa S.
Uemura S.
Tetrahedron
Lett.
1994,
35:
1739
<A NAME="RU06208ST-6">6 </A>
Mori A.
Danda Y.
Fujii T.
Hirabayashi K.
Osakada K.
J. Am. Chem.
Soc.
2001,
123:
10774
<A NAME="RU06208ST-7">7 </A>
Koike T.
Du X.
Sanada T.
Danda Y.
Mori A.
Angew. Chem.
Int. Ed.
2003,
42:
89
<A NAME="RU06208ST-8">8 </A>
Farrington EJ.
Brown JM.
Barnard CFJ.
Rowsell E.
Angew.
Chem. Int. Ed.
2002,
41:
169
<A NAME="RU06208ST-9">9 </A>
Beletskaya IP.
Cheprakov AV.
Chem. Rev.
2000,
100:
3009
<A NAME="RU06208ST-10">10 </A>
Arai Y.
Ueda K.
Xie J.
Masaki Y.
Chem. Pharm. Bull.
2001,
49:
1609
<A NAME="RU06208ST-11A">11a </A>
Clark WM.
Tickner-Eldridge AM.
Huang GK.
Pridgen LN.
Olsen MA.
Mills RJ.
Lantos I.
Baine NH.
J.
Am. Chem. Soc.
1998,
120:
4550
<A NAME="RU06208ST-11B">11b </A>
Elliott JD.
Amparo M.
Cousins RD.
Gao A.
Leber JD.
Erhard KF.
Nambi P.
Elshourbagy NA.
Kumar C.
Lee JA.
Bean JW.
Brooks CP.
Feuerstein G.
Ruffolo RR., Jr.
Weinstock J.
Gleason JG.
Peishoff CE.
Ohlstein EH.
J. Med. Chem.
1994,
37:
1553
<A NAME="RU06208ST-12A">12a </A>
Kato Y.
Niiyama K.
Nemoto T.
Jona H.
Akao A.
Okada S.
Song ZJ.
Zhao M.
Tsuchiya Y.
Tomimoto K.
Mase T.
Tetrahedron
2002,
58:
3409
<A NAME="RU06208ST-12B">12b </A>
Song ZJ.
Zhao M.
Frey J.
Li L.
Tan CY.
Chen DM.
Tschaen R.
Tillyer EJJ.
Grabowski L.
Volante R.
Reider PJ.
Kato Y.
Okada S.
Nemoto T.
Sato H.
Akao A.
Mase T.
Org.
Lett.
2001,
3:
3357
<A NAME="RU06208ST-13">13 </A>
General Procedure :
A flask charged with [Pd((S ,S )-chiraphos)(PhCN)2 ](SbF6 )2 [(S ,S )-3 ; 1 mol%], ArB(OH)2 (1.5
mmol) and 1 (0.5 mmol) was flushed with
nitrogen. Acetone (2 mL) and H2 O (0.2 mL) were then added.
After stirring for 20 h at 50 ˚C, the product was isolated
by chromatography on silica gel. The enantiomer excess was determined
by Chiral HPLC using Daicel Chiralpak IA, IB or IC.